GlassScriptPhysician profile
Sarah Jamieson
NPI 1982771986
$673.45
in general payments reported to CMS, 2019-2025
9 companies · $37.59 in 2025
The $37.59 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $105 · 2021: $63.69 · 2022: $40.77 · 2023: $58.02 · 2024: $15.13 · 2025: $37.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $282.64 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $175.18 | 2020-2025 | Ajovy |
| Tactile Systems Technology INC | $62.54 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $38.95 | 2023 | Ztlido |
| Novartis Pharmaceuticals Corporation | $36.21 | 2019 | |
| Currax Pharmaceuticals LLC | $25.77 | 2020 | |
| Upsher-Smith Laboratories LLC | $23.47 | 2020 | |
| Pfizer INC. | $15.13 | 2024 | |
| Abbvie INC. | $13.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Jamieson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.